跳至主要内容
临床试验/NCT04377854
NCT04377854招募中不适用

The Prognostic Value of proBNP in Patients Supported With Durable Mechanical Circulatory Assist Devices - a 25 Year Follow up Study.

Rigshospitalet, Denmark1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2020年9月18日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,000
试验地点
1
主要终点
Dead

研究概览

简要总结

A biobank has been created to investigate the prognostic value of biomarkers (mainly BNP) in patients implanted with durable mechanical assist devices comparing patients with advanced HF supported by MCS with those who are transplanted and those who remain on optimal medical therapy.

Patients will be followed up for 25 years after inclusion.

详细描述

All patients referred for advanced HF treatment at the Dept of Cardiology at Rigshospitalet.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients referred for evaluation for advanced HF treatment at the Rigshospital in Denmark
  • Age>18 years

排除标准

  • No consent

结局指标

主要结局

Dead

时间窗: 25 years from inclusion

Dead after inclusion in study

Alive

时间窗: 25 years from inclusion

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Finn Gustafsson

Professor

Rigshospitalet, Denmark

研究点 (1)

Loading locations...

相似试验